p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma

@article{Lim2010p53IT,
  title={p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma},
  author={Seung-Oe Lim and Hongtae Kim and G. Jung},
  journal={FEBS Letters},
  year={2010},
  volume={584}
}
MINT‐7718939: Snai1 (uniprotkb:O95863) physically interacts (MI:0915) with MDM2 (uniprotkb:Q00987) by anti tag coimmunoprecipitation (MI:0007) 
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Expression of the essential EMT inducer Snail1 is inhibited by miR-34 through a p53-dependent regulatory pathway.
USP26 promotes esophageal squamous cell carcinoma metastasis through stabilizing Snail.
TLDR
This observation demonstrates that USP26 is a novel deubiquitinating enzyme of Snail and it provides a potential target for the therapy of esophageal cancer metastasis. Expand
MDM 2p 53 Interactions in Human Hepatocellular Carcinoma : What Is the Role of Nutlins and New Therapeutic Options ?
Human hepatocellular carcinoma (HCC) is the fifth most common cancer and is associated with poor prognosis worldwide. The molecular mechanisms underlying the pathogenesis of HCC have been an area ofExpand
New plays in the p53 theater.
  • Y. Aylon, M. Oren
  • Biology, Medicine
  • Current opinion in genetics & development
  • 2011
TLDR
The p53 tumor suppressor and its paralogs p63 and p73 are at the crux of a network modulating cellular responses against potentially tumorigenic events, and a growing number of non-canonical target genes have been added to the p53 repertoire. Expand
Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
TLDR
The oncogenic roles of iASPP, an inhibitor of WT p53, in promoting proliferation, invasion, drug or radiation-resistance and metastasis, and promising perspectives of microRNA-124, peptide and small molecules that reduce or block iAS PP for the treatment of cancer are summarized. Expand
MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
  • S. Azer
  • Medicine
  • Journal of clinical medicine
  • 2018
TLDR
The molecular mechanisms involved in the p53-MDM2 pathways, the biological factors influencing these pathways, and their roles in the pathogenesis of HCC are outlined and the action of Nutlin-3 treatment in inducing growth arrest in HCC is discussed and elaborates on future directions in research in this area. Expand
Notch1 binds and induces degradation of Snail in hepatocellular carcinoma
TLDR
This study demonstrates that Notch1 intracellular domain (NICD) can oppose Snail-dependent HCC cell invasion by binding and inducing proteolytic degradation of Snail. Expand
p73 induction by Abrus agglutinin facilitates Snail ubiquitination to inhibit epithelial to mesenchymal transition in oral cancer.
  • N. Sinha, B. R. Meher, +4 authors S. Bhutia
  • Chemistry, Medicine
  • Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 2019
TLDR
AGG stimulates p73 in restricting EGF-induced EMT, invasiveness, and stemness by inhibiting the ERK/Snail pathway to facilitate the development of alternative therapeutics for oral cancer. Expand
Regulation of the protein stability of EMT transcription factors
TLDR
This review analyzes the current mechanisms controlling degradation of EMT transcription factors, focusing on the role of new E3 ubiquitin-ligases involved in EMT and the regulation of the stability of these EMT regulation factors, specially observed in different stress conditions. Expand
p53–Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT
TLDR
This study demonstrates the ability of wild-type p53 to promote the degradation of Twist1 protein and suggests a signaling pathway that can potentially be used to develop new prognostic markers and therapeutic targets to curtail cancer progression. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
TLDR
The identification of Snail, ZEB and some basic helix-loop-helix factors as inducers of epithelial–mesenchymal transition (EMT) and potent repressors of E-cadherin expression has opened new avenues of research with potential clinical implications. Expand
p53 ubiquitination: Mdm2 and beyond.
TLDR
Growing evidence challenges the conventional view that Mdm2 is essential for p53 turnover, and the discoveries of MdmX, HAUSP, ARF, COP1, Pirh2, and ARF-BP1 continue to uncover the multiple facets of this pathway. Expand
Live or let die: the cell's response to p53
TLDR
Understanding the complex mechanisms that regulate whether or not a cell dies in response to p53 will ultimately contribute to the development of therapeutic strategies to repair the apoptotic p53 response in cancers. Expand
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
TLDR
This Review of in vitro studies, human tumour data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 andMDM4 have more profound roles for regulating p53. Expand
p53, the Cellular Gatekeeper for Growth and Division
TLDR
The author regrets the lack of citations for many important observations mentioned in the text, but their omission is made necessary by restrictions in the preparation of review manuscripts. Expand
Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function.
TLDR
The evidence that oncogenic K-Ras abrogates p53 function and expression through induction of Ataxia telangiectasia-mutated and Rad3-related mediated Snail stabilization is provided and the Snail-p53 binding is proposed as the new therapeutic target for K- Ras-mutation cancers including pancreatic, lung, and colon cancers. Expand
Modes of p53 Regulation
TLDR
It is proposed that antirepression, the release of p53 from repression by factors such as Mdm2 and MdmX, is a key step in the physiological activation of p 53. Expand
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
TLDR
It is shown that wild-type p53 (wtp53) suppresses cancer invasion by inducing Slug degradation, whereas mutant p53 may stabilize Slug protein, which indicates that wtp53 and p53 mutants may differentially control cancer invasion and metastasis through the p53–MDM2–Slug pathway. Expand
Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
TLDR
These findings provide novel mechanistic insights into epigenetic modulations induced by ROS in the process of carcinogenesis and are potentially relevant to understanding the activity of ROS in silencing various tumor suppressor genes and in subsequent tumor progression and metastasis. Expand
E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
TLDR
In vivo evidence is provided that HDACs and Snail play an essential role in silencing E-cadherin during the metastatic process of pancreatic cancer cells, and link the epigenetic HDAC machinery to EMT and metastasis. Expand
...
1
2
3
...